Humane Genomics

New York, NY · Founded 2016 · Privately Held (backing)

Developer of a synthetic virology platform designed to engineer oncolytic viral therapies for cancer treatment. Humane Genomics is based in New York, NY and was founded in 2016. Its last reported valuation was $17 million in Feb 2025. It has raised $8.1 million.

Last reported valuation
$17.0M
Oct 2026
Priced at
—
Total raised
$8.1M
Last round
—

Who backs Humane Genomics?

17 investors
InvestorType
Y CombinatorOther
Creative Destruction LabOther
Mana VenturesVenture capital
GaingelsVenture capital
University of TorontoOther
Union Square VenturesVenture capital
Asymmetry VenturesVenture capital
TA VenturesVenture capital
Scale Asia VenturesVenture capital
2048 VenturesVenture capital
+ 7 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Humane Genomics investors

17 investors are on record for Humane Genomics, including Y Combinator, Creative Destruction Lab, Mana Ventures and Gaingels. By type, the record holds 10 venture capital firms.

Free account
More of Humane Genomics with a free account
  • ·The complete investor list: 17 names
  • ·Watch Humane Genomics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like Humane Genomics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View